IBEX (NASDAQ:IBEX) Posts Earnings Results, Beats Expectations By $0.05 EPS

IBEX (NASDAQ:IBEX) issued its quarterly earnings results on Wednesday. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.05, FiscalAI reports. The business had revenue of $164.41 million during the quarter, compared to analyst estimates of $157.00 million. IBEX had a net margin of 7.35% and a return on equity of 31.70%.

Here are the key takeaways from IBEX’s conference call:

• Record quarterly results with revenue up 17% to $164.4 million, Adjusted EPS up 11% to $0.91, and a record Adjusted EBITDA of $22.0 million, marking multiple consecutive quarters of double‑digit growth.
• Announced a strategic partnership with Sierra to integrate their AI agent technology with IBEX’s CX capabilities, with management citing rapid deployments, early wins, and expectations that AI services will be accretive to margins.
• The health tech vertical is a major growth driver—up ~54% and expected to exceed $100 million this fiscal year—driven by new large logos and share gains that management describes as sustainable.
• Raised FY26 guidance to $638–$642 million revenue and $82–$84 million Adjusted EBITDA, while increasing CapEx guidance to $25–$30 million to fund capacity expansion and AI investments.
• Management recorded $0.8 million of severance related to a nearshore‑to‑offshore volume shift, noted a ~40 bps decline in Adjusted EBITDA margin for the quarter, and expects an additional asset impairment charge in Q4 as it adjusts capacity.

IBEX Trading Down 0.8%

IBEX stock traded down $0.24 during mid-day trading on Wednesday, reaching $28.11. The company’s stock had a trading volume of 107,260 shares, compared to its average volume of 105,024. The firm has a market cap of $376.96 million, a price-to-earnings ratio of 9.25 and a beta of 0.66. The business has a 50 day moving average price of $28.33 and a 200-day moving average price of $33.42. IBEX has a twelve month low of $25.00 and a twelve month high of $42.99.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on IBEX shares. Weiss Ratings lowered shares of IBEX from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Thursday, February 5th. Wall Street Zen upgraded shares of IBEX from a “buy” rating to a “strong-buy” rating in a research note on Saturday, February 21st. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $35.00.

Insiders Place Their Bets

In other news, insider Michael Joseph Darwal sold 1,660 shares of the business’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $34.98, for a total transaction of $58,066.80. Following the completion of the transaction, the insider owned 42,185 shares of the company’s stock, valued at approximately $1,475,631.30. The trade was a 3.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Paul Joseph Inson sold 2,627 shares of the business’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $34.98, for a total transaction of $91,892.46. Following the transaction, the insider directly owned 27,469 shares of the company’s stock, valued at approximately $960,865.62. This trade represents a 8.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 16,287 shares of company stock valued at $498,499 over the last 90 days. 3.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On IBEX

Hedge funds and other institutional investors have recently modified their holdings of the company. Advisory Services Network LLC acquired a new position in shares of IBEX during the third quarter valued at $46,000. Amundi acquired a new position in shares of IBEX during the first quarter valued at $74,000. Empowered Funds LLC acquired a new position in shares of IBEX during the fourth quarter valued at $84,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of IBEX by 8.6% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,466 shares of the company’s stock valued at $159,000 after acquiring an additional 434 shares during the period. Finally, Quantbot Technologies LP boosted its holdings in shares of IBEX by 18,435.1% during the second quarter. Quantbot Technologies LP now owns 6,858 shares of the company’s stock valued at $200,000 after acquiring an additional 6,821 shares during the period. Institutional investors and hedge funds own 81.24% of the company’s stock.

About IBEX

IBEX Holdings, Inc is a global business process outsourcing (BPO) company that specializes in customer experience solutions for a range of industries, including telecommunications, cable, technology, financial services and e-commerce. The company’s core offerings encompass multichannel customer support delivered via voice, email, chat, social media and digital self-service platforms. In addition to front-line contact center services, IBEX provides back-office processing, order management, technical troubleshooting and analytics-driven insights to help clients optimize operational efficiency and customer satisfaction.

Beyond traditional contact center operations, IBEX has built a proprietary technology stack designed to integrate real-time data analytics, workforce management and quality assurance.